Welcome to our dedicated page for Criteo S.A. news (Ticker: CRTO), a resource for investors and traders seeking the latest updates and insights on Criteo S.A. stock.
Criteo S.A. (NASDAQ: CRTO) is a global leader in commerce media, headquartered in Paris. The company specializes in performance marketing technology, enabling e-commerce companies to leverage vast amounts of data for effective customer engagement and conversion. With its predictive software algorithms and deep insights into consumer behavior, Criteo provides highly relevant and personalized advertisements in real-time, optimizing advertising placement decisions based on data and activity on client websites.
Criteo operates in 130 countries, with a strong workforce of over 1,600 employees across 27 offices worldwide. The company partners with more than 8,500 clients and maintains direct relationships with over 11,000 publishers. Its innovative technology allows retailers to launch multichannel and cross-device marketing campaigns in real-time, providing real-time ROI analysis to dynamically adjust marketing strategies. Additionally, Criteo's technology aids retailers in managing ad inventories and enhancing yield optimization.
In Q3 2023, Criteo reported a revenue of $469 million, gross profit of $205 million, and a Contribution ex-TAC of $245 million. The company witnessed significant growth, with a gross profit margin of 44% and a Contribution ex-TAC margin of 52%. For the fiscal year 2023, revenue was $1.9 billion, and net income reached $55 million. Criteo's robust financial performance is attributed to its strategic focus on retail media and cost efficiencies.
Recent achievements include a partnership with Albertsons to enhance its retail media offerings, the introduction of new ad formats like commerce display and sponsored video, and the attainment of MRC accreditation for display rendered impression and click advertising metrics. These initiatives underscore Criteo’s commitment to innovation and transparency in the retail media space.
Looking ahead, Criteo remains focused on sustainable growth, with an emphasis on expanding its Commerce Media Platform and driving shareholder value. The company projects a positive outlook for 2024, with plans to further enhance its market presence and operational efficiencies.
2seventy bio officially launches as an independent, publicly traded company on Nasdaq under the symbol TSVT on November 5. The company, a spin-off from bluebird bio, presents a robust pipeline in immuno-oncology cell therapies, including the recently approved ABECMA for multiple myeloma, which garnered $67 million in its first full quarter. The company is backed by approximately $442 million in cash, ensuring operational funding into 2023. With plans for innovative clinical studies in hematologic and solid tumors, 2seventy aims to transform cancer treatment.
Criteo S.A. (NASDAQ: CRTO) announced that CEO Megan Clarken will present at the Morgan Stanley European Technology, Media & Telecom Conference on November 17, 2021, at 1:15 PM Eastern Time. A live audio webcast will be available on the Company's investor relations website, with a replay option afterward. Criteo partners with over 20,000 marketers globally, leveraging extensive commerce data to enhance advertising and consumer experiences. More details can be found at www.criteo.com.
Criteo S.A. (NASDAQ: CRTO) reported strong Q3 2021 financial results, with revenue reaching $509 million, up 8% year-over-year. The company achieved a net income of $24 million, a 358% increase, resulting in diluted EPS of $0.37. Gross profit also grew by 16% to $176 million. Revenue excluding traffic acquisition costs (ex-TAC) rose 13% to $211 million. Criteo's operating cash flow remained stable at $51 million, with free cash flow decreasing to $35 million. The company raised its full-year financial guidance, reflecting ongoing business momentum and solid execution of its Commerce Media Platform strategy.
LiveRamp (NYSE: RAMP) reported a strong financial performance for Q2 fiscal 2022, with total revenue increasing by 22% to $127 million. Subscription revenue rose by 23% to $105 million, constituting 83% of total revenue. GAAP gross margin expanded to 72%, while non-GAAP gross margin reached 77%. The company achieved a record operating performance, adding 15 new direct subscription customers, bringing the total to 870. LiveRamp’s outlook for fiscal 2022 has been raised, expecting revenue of $525 million and non-GAAP operating income of $40 million.
Tilak Healthcare has successfully completed a €7 million fundraising round led by Elaia with participation from Swen Capital Partners, Matmut Innovation, and the iBionext Growth Fund. This funding will support the international rollout of its mobile vision testing platform, OdySight, which has already been adopted by nearly 20% of retinologists in France. The platform, designed for remote monitoring of visual health, aims to address the needs of the 2.2 billion people with vision impairment globally.
Criteo S.A. (NASDAQ: CRTO) is set to announce its financial results for Q3 2021 on November 3, 2021. CEO Megan Clarken and CFO Sarah Glickman will host a conference call at 8:00 AM ET, alongside Chief Product Officer Todd Parsons. U.S. callers can join at +1 855 209 8212, while international callers can access the call at +1 412 317 0788 or +33 1 76 74 05 02. The call will also be streamed live via the Criteo website, with a replay available afterward.
Shippeo, a leader in real-time transportation visibility, reported a remarkable 103% year-on-year growth in subscription revenues and a 181% net retention rate. The company welcomed numerous international brands, including Coca-Cola HBC and Nexans, expanding its global footprint. Shippeo's employee count has increased to over 230, with plans to double its workforce by the end of 2021. The company maintains a 0% customer churn rate, emphasizing enhanced product offerings and partnerships with leading supply chain firms.
bluebird bio has announced a tax-free spin-off of its oncology programs into 2seventy bio, with a completion timeline of early November 2021. Shareholders will receive 1 share of 2seventy bio for every 3 shares of bluebird bio owned. The company expects approximately
Optimove, a CRM marketing leader, secured a $75 million investment from Summit Partners aimed at enhancing M&A strategy, hiring, and expanding its SaaS platform for customer engagement and retention. This funding will enable Optimove to accelerate growth, as it continues to maintain healthy profit margins while generating over 40% revenue growth in the past year. The company currently sends more than 23 billion marketing messages annually and serves over 500 brands globally. Summit Partners' executives will join Optimove's Board of Directors.
InMobi announces the appointment of Joe Esposito to lead its new Agency Partnerships team, aiming to enhance ties with major agencies in North America. Reporting to Greg Archibald, Esposito brings nearly 20 years of digital marketing experience, particularly from his roles in Criteo and Rio SEO. His expertise lies in fostering agency relationships and driving innovation in demand and supply-side solutions. Esposito's leadership is expected to support InMobi's growth strategy while addressing current industry challenges faced by agencies.
FAQ
What is the current stock price of Criteo S.A. (CRTO)?
What is the market cap of Criteo S.A. (CRTO)?
What does Criteo S.A. specialize in?
Where is Criteo headquartered?
How many countries does Criteo operate in?
What were Criteo’s financial highlights for Q3 2023?
What is Criteo's Commerce Media Platform?
How many employees does Criteo have?
What recent partnership did Criteo announce?
What are Criteo's future growth plans?
What accreditation has Criteo recently achieved?
What are Criteo's core services?
